All articles by Abi Millar

  1. Cannabinoids breakthrough signals hope for epilepsy treatment

    On 25h June 2018, the US Food and Drug Administration (FDA) approved Epidiolex, a cannabinoid-based medicine for treating seizures in…
    Read More…

    3 Sep
  2. Philanthropy in pharma: a look inside the ISPE Foundation

    In June, the International Society of Pharmaceutical Engineering (ISPE) launched the ISPE Foundation, its philanthropic arm. Funded exclusively through donations,…
    Read More…

    29 Aug
  3. Could cutting out mediators let cancer research off the leash?

    In 2014, Bristol Myers Squibb (BMS) and The University of Texas MD Anderson Cancer Center announced a pioneering research collaboration….
    Read More…

    13 Aug
  4. The next generation of antimalarials

    Over the last two decades, the fight against malaria has been overwhelmingly successful. Between 2000 and 2015, global malaria deaths…
    Read More…

    7 Aug
  5. Paying the bill for innovative gene and cell therapies

    Our new era of precision medicine holds great promise for patients. If therapies can be tailored to their exact needs…
    Read More…

    2 Aug
  6. Immunising against opioids: could a vaccine solve the crisis?

    The US opioid crisis may seem like a near-unsolvable problem. With 115 people dying from opioid overdoses every day (be…
    Read More…

    31 Jul
  7. Opening up the Chinese drug market

    China’s pharmaceutical market is in great shape. The second largest in the world, coming in just behind the US, it…
    Read More…

    5 Jul
  8. A formula for success: inside Swiss pharma

    The city of Basel, where the Swiss, French and German borders meet, is known for its museums, medieval Old Town…
    Read More…

    13 Jun
  9. Gut instinct: how common drugs affect the microbiome

    In recent years, the human microbiome has become an exciting field of study. Spurred by advances in sequencing technology, along…
    Read More…

    12 Jun
  10. Unlocking cell-free protein synthesis: biotech’s next big ticket?

    In recent years, cell-free protein synthesis (CFPS) has emerged as a powerful new technology, with a wide range of potential…
    Read More…

    11 Jun